India to Get 100 Million Astra Vaccine Shots by Next Month
- Serum Institute ramps up production of shot awaiting approval
- CEO sees 90% of nations avoiding Pfizer shot due to logistics
Photographer: Vincenzo Pinto/AFP/Getty Images
This article is for subscribers only.
The world’s largest vaccine maker is ramping up production of AstraZeneca Plc’s Covid-19 shot, aiming to have 100 million doses ready by December for an inoculation drive that could begin across India that same month.
If final-stage trial data show AstraZeneca’s candidate gives effective protection from the virus, the Serum Institute of India Ltd. -- which is partnered to produce at least one billion doses -- may get emergency authorization from New Delhi by December, said Adar Poonawalla, chief executive officer of the family-owned firm based in the western city of Pune.